Ranjeet Ajmani: Southeast Asia – 25% of The Global Population Contributes Less than 2% of The Global Plasma Supply
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”It will be an honor to share experiences and insights at the Business Forum (October, 16, 2025) of the Plasma Protein Therapeutics Association (PPTA), Virginia, USA
Southeast Asia (SEA), home to over 2 billion people—about 25% of the global population—contributes less than 2% of the global plasma supply.
This disparity is clearly reflected in patient care, particularly in the availability, accessibility, and affordability of Plasma-Derived Medicinal Products (PDMPs).
The situation is further exacerbated by limited public healthcare expenditure, inadequate health policies, and regulatory challenges.
As a result, a vast majority of patients in developing countries remain undiagnosed.
Many live with serious, yet treatable, conditions—often in silence, suffering without support, and sadly passing away without ever receiving the care they need.
These stories are not just statistics—they are deeply human, and often heart-wrenching.
We must ask ourselves: Can we do more for our fellow citizens?
The answer must be yes.
By fostering collaboration across governments, regulators, industry, and patient advocacy groups, and by reimagining policies and infrastructure, we can build a more equitable future—one in which no one is left behind simply because of where they were born.”
Stay updated with Hemostasis Today.
-
Jun 10, 2026, 04:15Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
-
Jun 10, 2026, 04:02Heghine Khachatryan: What Should We Test From a Hematologic Perspective in Young Cryptogenic Stroke?
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients